manjaro tirzepatide india Mounjaro (Tirzepatide) Injection for Weight Loss Mounjaro in India - Tirzepatide
Description
Purpose-built for physicians SURMOUNT-2: Tirzepatide confers about 15% weight loss in adults with obesity and diabetes Key takeaways: At 72 weeks, adults receiving 10 mg tirzepatide lost 12.8% of body weight and those receiving 15 mg lost 14.7% of body weight
The FDA established two deadlines
Higher doses produce more weight loss and greater metabolic effects, but whether this translates to proportionally greater immune modulation is unknown
The practical guidance is the same: stop before trying to conceive, and dont use during pregnancy or breastfeeding until more data exists
Keep away from heat
